Navigation Links
Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles
Date:8/27/2012

.4.4 Colistimethate sodium (Colistin, Colomycin Injection, Promixin, Coly-Mycin M) 1326.5 Cystic Fibrosis – Promising Drugs Under Clinical Development 1336.5.1 Denufosol Tetrasodium Inhalation Solution (INS37217) 1336.5.2 VX-770 1346.5.3 Bronchitol 1346.5.4 Ataluren (PTC-124) 1356.6 Phase III – Clinical Trial Analysis 1366.6.1 Completed Trial Analysis 1366.6.2 Active Trial Analysis 1386.6.3 Terminated Trial Analysis 1416.7 Phase II – Clinical Trial Analysis 1436.7.1 Completed Trial Analysis 1436.7.2 Active Trial Analysis 1466.7.3 Terminated Trial Analysis 1497 Endpoints - Clinical Trials in Pulmonary Arterial Hypertension - Marketed and Pipeline Products Assessment 1567.1 Introduction 1567.1.1 Classification of Pulmonary Hypertension 1567.2 Primary Endpoints Used in Pulmonary Hypertension Trials 1617.2.1 Cardiopulmonary Hemodynamic Test 1617.2.2 Six Minutes Walking Distance 1617.2.3 Biomarkers 1617.3 Secondary Endpoints Used in Pulmonary Hypertension Trials 1617.3.1 Time to Clinical Worsening 1617.3.2 SF-36 Health Survey 1617.4 Pulmonary Arterial Hypertension – Major Marketed Drugs 1617.4.1 Tracleer 1617.4.2 Remodulin 1627.4.3 Revatio 1637.4.4 Ventavis 1647.4.5 Letairis 1657.4.6 Adcirca 1667.5 Pulmonary Arterial Hypertension – Promising Drugs under Clinical Development 1677.5.1 ACT-064992 1677.5.2 Oral Treprostinil 1687.5.3 ACT-293987 1687.5.4 Riociguat (BAY63-2521) 1697.6 Phase III Clinical Trial Analysis 1707.6.1 Completed Trial Analysis 1707.6.2 Active Trial Analysis 1727.6.3 Terminated Trial Analysis 1757.7 Phase II Clinical Trial Analysis 1777.7.1 Completed Trial Analysis 1777.7.2 Active Trial Analysis 1807.7.3 Terminated Trial Analysis 1838 Endpoints - Clinical Trials in Respiratory Diseases - Company Profiling 1878.1 GlaxoSmithKline Plc 1878.1.1 Overview 1878.1.2 Respiratory Disease Portfolio 1878.2 AstraZeneca 1888.2.1 Overview 1888.2.2 Respiratory Disease Portfolio 1888.3 F.Hoffmann La Roche 1888.3.1 Overview 1888.3.2 Respirato
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
2. As Tuberculosis Grows More Difficult to Control, Vaccine Candidate to Prevent Disease Enters Clinical Testing
3. Millennium Laboratories Announces Landmark Pharmacogenetics Clinical Outcomes Study
4. VolitionRX to Begin Prospective Clinical Trial in Colon Cancer
5. Indegene Introduces TrialPedia 2.0 with Advantage Insights, Making It the Most Comprehensive Clinical Trial Analytics and Decision Support Platform for the Pharma Industry
6. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
7. AbGenomics International Obtains FDA Agreement on Its Phase 2 Clinical Trial Plans
8. Nectid Announces Initiation Of Clinical Development Of Autism And Pain Drugs
9. Meritage Pharma Initiates Clinical Trial of Oral Budesonide Suspension for Adolescent and Adult Patients with Eosinophilic Esophagitis
10. MultiCell Technologies Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in vitro Models
11. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... NEW YORK , Aug. 20, 2014 /PRNewswire/ ... report is available in its catalogue: ... U.S. IVD Industry http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html ... Care Act" (H.R. 3590) is complex legislation that ... many of its provisions are beginning to take ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportbuyer.com has added ... Defibrillators Industry https://www.reportbuyer.com/product/98394/Global-Cardiac-Defibrillators-Industry.html ... in US$ Million by the following Product Segments: Implantable/Internal ... comprehensive analytics for the US, Canada ... , Asia-Pacific , ...
(Date:8/20/2014)... , August 20, 2014 ... market report titled "Monochloroacetic Acid (MCA) Market for Cellulosics, ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... valued at USD 817.1 million in 2013 and is ... at a CAGR of 3.6% during the forecast period ...
Breaking Medicine Technology:The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6Global Cardiac Defibrillators Industry 2Global Cardiac Defibrillators Industry 3Global Cardiac Defibrillators Industry 4Global Cardiac Defibrillators Industry 5Global Cardiac Defibrillators Industry 6Global Cardiac Defibrillators Industry 7Global Cardiac Defibrillators Industry 8Global Cardiac Defibrillators Industry 9Global Cardiac Defibrillators Industry 10Global Cardiac Defibrillators Industry 11Global Cardiac Defibrillators Industry 12Global Cardiac Defibrillators Industry 13Global Cardiac Defibrillators Industry 14Global Cardiac Defibrillators Industry 15Global Cardiac Defibrillators Industry 16Global Cardiac Defibrillators Industry 17Global Cardiac Defibrillators Industry 18Global Cardiac Defibrillators Industry 19Global Cardiac Defibrillators Industry 20Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4
... July 30 Peptimmune, Inc. a privately,held ... US Patent Number,7,381,790 (the ,790 patent) which ... peptide copolymer for the treatment of autoimmune ... Phase Ib multiple-ascending dose,double-blind, placebo-controlled randomized study ...
... issues a review of,Generex Biotechnology Corporation (Nasdaq: ... Platform, Sets the Tone as Best in,Class Followed ... This review is available at website: http://www.scimitarequity.com ... development, and commercialization,of drug delivery systems and technologies. ...
Cached Medicine Technology:Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 2Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 3Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC 2
(Date:8/20/2014)... An Elle Magazine online report dated August 13, 2014 ... at Every Age,” offers a set of recommendations to help ... These recommendations are offered as a preventative skincare plan. The ... beyond. The first group of recommendations can be universally applied ... sunscreen religiously, getting sufficient exercise and sleep, and eating well. ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 A new ... require a medical exam before issuing an approximate quote ... Pros company is now helping the public to obtain ... its system at http://quotespros.com/life-insurance.html . , The ... as more regulations have appeared in many U.S. states. ...
(Date:8/20/2014)... By Dennis Thompson ... -- U.S. teen birth rates fell dramatically during the past ... dollars, a new government report shows. An estimated 4 ... the decline, according to researchers from the U.S. Centers for ... "leapt out at me from the report," said Bill Albert, ...
(Date:8/20/2014)... the immune system is defective in people suffering from irritable ... ongoing issues with pain. , The research the first ... to explain why some painkillers may not offer satisfactory relief ... 10% of the community. There are different forms of ... often has the greatest impact on sufferers, quality of life. ...
(Date:8/20/2014)... 2014 (HealthDay News) -- Pigs, hearts transplanted into baboons ... as long as previously achieved, researchers report. The ... use animal organs to shorten transplant waiting lists. ... piglets into baboons, abdomens. The genetic engineering and new ... what enabled the hearts to survive for more than ...
Breaking Medicine News(10 mins):Health News:Simon Ourian, Kim Kardashian’s Doctor, On Healthy Skin Suggestions for Every Age 2Health News:Life Insurance Quotes Without Medical Exams Now Displayed to Adults at Insurance Website 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 3Health News:Pain treatments less effective for those with irritable bowel 2Health News:Pigs' Hearts Beat for a Year in Baboons' Abdomens 2
... in minimally invasive surgical techniques -- most notably, ... common surgical option across the United States for ... , A newer, third option is a hybrid ... safe and effective and compares favorably with standard ...
... Software Complies with 100% of Updated Interoperability RequirementsTAMPA, ... a leading provider of electronic health records, today ... Technology (CCHIT(R)) has approved Sage,s product, Sage Intergy ... Ambulatory EHR , additionally certified ...
... Managing Turnover According to Cejka Search and AMGA ... to the current economic crisis is that physicians ... However, with the physician shortage intensifying and ... sharpening their competitive edge in finding and keeping ...
... surgical approach to treat stomach cancer has been shown ... treatment for some patients. , A new study led ... traditional "open" surgery to remove the stomach with laparoscopic ... surgeon removes the stomach while guided by a magnified ...
... thyroid cancer is being held today at the United Nations ... of thyroid cancer among millions of people around the world ... in Ukraine on April 26, 1986. ... (NYEEI) is working in partnership with Project Chernobyl, a ...
... Therapeutics, Inc. announced today positive results from a ... evaluating fenretinide for the treatment of geographic atrophy ... analysis was triggered when all patients had reached ... http://www.newscom.com/cgi-bin/prnh/20080220/CLW064LOGO )The analysis compared the ...
Cached Medicine News:Health News:Helping hand of hybrid surgery benefits colorectal patients 2Health News:Sage Intergy EHR Receives 08 CCHIT Certification 2Health News:Sage Intergy EHR Receives 08 CCHIT Certification 3Health News:Sage Intergy EHR Receives 08 CCHIT Certification 4Health News:Sage Intergy EHR Receives 08 CCHIT Certification 5Health News:The Economy Plus Flexibility Keep Physicians in Practice 2Health News:The Economy Plus Flexibility Keep Physicians in Practice 3Health News:The Economy Plus Flexibility Keep Physicians in Practice 4Health News:New minimally invasive surgery option for patients with stomach cancer 2Health News:'Living With Radiation' Conference Commemorating Chernobyl Nuclear Disaster Held at United Nations, Sponsored by New York Eye & Ear Infirmary 2Health News:Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide 2Health News:Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide 3
Inquire...
... in laser treatment, brings remarkable results and ... EVLT is a minimally invasive, clinically proven ... and safely treats varicose veins using a ... The procedure is easy to perform and ...
... The Aculens 186 UV combines the latest ... include measurement of ultra violet transmission and ... 186 is also programmed to network with ... VELO Instruments, today, or in the future. ...
Inquire...
Medicine Products: